Camlin Fine Sciences has extended the timeline to complete its majority stake acquisition in Vinpai S.A. to September-end due to delayed documentation from the foreign sellers.

Meanwhile, Camlin invested €3.3 million via secured convertible bonds in Vinpai, with bond maturity extended to late October.

This acquisition aims to enhance Camlin’s product portfolio and expand its presence internationally.

The deal’s completion will add strategic value by tapping into Vinpai’s expertise and markets, positioning Camlin for growth in specialty chemicals and ingredients.